BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8953283)

  • 1. O-GlcNAcylation of key nuclear and cytoskeletal proteins: reciprocity with O-phosphorylation and putative roles in protein multimerization.
    Hart GW; Kreppel LK; Comer FI; Arnold CS; Snow DM; Ye Z; Cheng X; DellaManna D; Caine DS; Earles BJ; Akimoto Y; Cole RN; Hayes BK
    Glycobiology; 1996 Oct; 6(7):711-6. PubMed ID: 8953283
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: a new paradigm for metabolic control of signal transduction and transcription.
    Kamemura K; Hart GW
    Prog Nucleic Acid Res Mol Biol; 2003; 73():107-36. PubMed ID: 12882516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens.
    Kamemura K; Hayes BK; Comer FI; Hart GW
    J Biol Chem; 2002 May; 277(21):19229-35. PubMed ID: 11904304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins.
    Hart GW
    Annu Rev Biochem; 1997; 66():315-35. PubMed ID: 9242909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylation of the c-Myc transactivation domain.
    Chou TY; Dang CV; Hart GW
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4417-21. PubMed ID: 7753821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of O-linked N-acetylglucosamine modification in diabetic nephropathy.
    Gellai R; Hodrea J; Lenart L; Hosszu A; Koszegi S; Balogh D; Ver A; Banki NF; Fulop N; Molnar A; Wagner L; Vannay A; Szabo AJ; Fekete A
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1172-F1181. PubMed ID: 27029430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
    Vosseller K; Wells L; Lane MD; Hart GW
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and identification of protein O-GlcNAcylation sites with substrate specificity.
    Wu HY; Lu CT; Kao HJ; Chen YJ; Chen YJ; Lee TY
    BMC Bioinformatics; 2014; 15 Suppl 16(Suppl 16):S1. PubMed ID: 25521204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protein O-GlcNAcylation and regulation of cell signalling: involvement in pathophysiology].
    Issad T; Pagesy P
    Biol Aujourdhui; 2014; 208(2):109-17. PubMed ID: 25190571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies.
    Freund P; Kerenyi MA; Hager M; Wagner T; Wingelhofer B; Pham HTT; Elabd M; Han X; Valent P; Gouilleux F; Sexl V; Krämer OH; Groner B; Moriggl R
    Leukemia; 2017 Oct; 31(10):2132-2142. PubMed ID: 28074064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAc modification affects the ATM-mediated DNA damage response.
    Miura Y; Sakurai Y; Endo T
    Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global O-GlcNAcylation changes impact desmin phosphorylation and its partition toward cytoskeleton in C2C12 skeletal muscle cells differentiated into myotubes.
    Claeyssen C; Bastide B; Cieniewski-Bernard C
    Sci Rep; 2022 Jun; 12(1):9831. PubMed ID: 35701470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of O-GlcNAcylation.
    Hurtado-Guerrero R; Dorfmueller HC; van Aalten DM
    Curr Opin Struct Biol; 2008 Oct; 18(5):551-7. PubMed ID: 18822376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-linked N-acetylglucosamine: the "yin-yang" of Ser/Thr phosphorylation? Nuclear and cytoplasmic glycosylation.
    Hart GW; Greis KD; Dong LY; Blomberg MA; Chou TY; Jiang MS; Roquemore EP; Snow DM; Kreppel LK; Cole RN
    Adv Exp Med Biol; 1995; 376():115-23. PubMed ID: 8597237
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.
    Gatta E; Lefebvre T; Gaetani S; dos Santos M; Marrocco J; Mir AM; Cassano T; Maccari S; Nicoletti F; Mairesse J
    Pharmacol Res; 2016 Mar; 105():186-97. PubMed ID: 26816085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered O-GlcNAc modification and phosphorylation of mitochondrial proteins in myoblast cells exposed to high glucose.
    Gu Y; Ande SR; Mishra S
    Arch Biochem Biophys; 2011 Jan; 505(1):98-104. PubMed ID: 20887712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The O-β-linked N-acetylglucosaminylation of the Lamin B receptor and its impact on DNA binding and phosphorylation.
    Smet-Nocca C; Page A; Cantrelle FX; Nikolakaki E; Landrieu I; Giannakouros T
    Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):825-835. PubMed ID: 29337275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distributive O-GlcNAcylation on the Highly Repetitive C-Terminal Domain of RNA Polymerase II.
    Lu L; Fan D; Hu CW; Worth M; Ma ZX; Jiang J
    Biochemistry; 2016 Feb; 55(7):1149-58. PubMed ID: 26807597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-GlcNAcylation of amyloid-β precursor protein at threonine 576 residue regulates trafficking and processing.
    Chun YS; Kwon OH; Chung S
    Biochem Biophys Res Commun; 2017 Aug; 490(2):486-491. PubMed ID: 28624365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of O-GlcNAc modification of cellular proteins in signal transduction].
    Krześlak A
    Postepy Biochem; 2007; 53(4):389-99. PubMed ID: 19024903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.